MMSI Merit Medical Systems Inc.

Merit Medical to Participate in Two Upcoming Investor Conferences

Merit Medical to Participate in Two Upcoming Investor Conferences

SOUTH JORDAN, Utah, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will participate in two upcoming investor conferences.

On Wednesday, January 13, at 2:00 p.m. ET, Fred P. Lampropoulos, President and Chief Executive Officer of Merit, and Raul Parra, Merit’s Chief Financial Officer, will present at the 23rd Annual Needham Growth Conference, which is being held virtually. They will also host virtual one-on-one meetings throughout the day.

On Thursday, January 14, at 2:30 p.m. ET, Messrs. Lampropoulos and Parra will host a fireside chat at the ICR Conference 2021, which is being held virtually. They will also host virtual one-on-one meetings throughout the day.

ABOUT MERIT

Founded in 1987, Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

Contacts:



 
PR/Media Inquiries:

Teresa Johnson

Merit Medical
Investor Inquiries:

Mike Piccinino, CFA, IRC

Westwicke - ICR





EN
07/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year...

Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance Highlights† Reported revenue of $384.2 million, up 13.0%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, respectivelyGAAP operating margin of 11.1%, compared to 11.0% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.2% in prior year periodGAAP EPS $0.46, down 3.0%Non-GAAP EPS* $0.92, up 6.7%Free cash flow* generation of $141.6 million over first nine months of 2025, up 17.6% year-over-year † Comparisons above are calculated for the current quarter ...

 PRESS RELEASE

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Ac...

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders. Asset acquisition is projected to add approximately $6 million to $8 million of revenue in 2026 in a key gastroenterology market that leverages Merit’s existing commercial footprint.   SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare tech...

 PRESS RELEASE

Merit Medical Systems to Announce Third Quarter 2025 Results on Octobe...

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). ...

 PRESS RELEASE

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with...

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced a significant milestone for breast cancer treatment: SCOUT® Radar Localization use has reached 750,000 patients worldwide.1 This global achievement coincides with Breast Cancer Awareness Month, a time dedicated to educating the public about the ...

 PRESS RELEASE

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Ar...

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolisation (GAE) to treat patients with knee osteoarthritis (OA). The...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch